Disease management
The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The company will use the funds to advance product innovation, strengthen clinical partnerships and accelerate its nationwide growth.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.
The Elton John AIDS Foundation, one of the first financial backers of Zipline and an established partner of the company, made the announcement.
The Greek government will integrate Sword Intelligence into the country's National Health Information Line to workers with triage and care coordination.
Former Zuellig Pharma exec Louis Payet launches Peach Health Asia, aiming to make coach-guided tele-physiotherapy and digital rehabilitation accessible across Southeast Asia.
Also, a Taiwanese consortium is expanding across the Japanese elderly care sector.